• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Akne-Mycin
    / Neopharm

    Active Ingredient

    Status in Israel

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft


    25 ml

    full basket chart 210 1169


    Generally the solution should be applied twice a day.
    The bottle has a special applicator; with this Aknemycin can be applied directly on to the skin.
    The applicator bottle is prepared for use each time by pressing vigorously on the applicator beforehand with the reversed cap. This releases the safety mechanism and Aknemycin can be applied.
    Treatment with Aknemycin should not be longer than 4 – 6 weeks.




    Aknemycin must not be used in cases of – hypersensitivity to the active substance or to any of the excipients.

    Special Precautions

    Aknemycin should not be allowed to get into the eyes.

    Side Effects

    Very rare: drying, reddening, burning and itching of the skin. In these cases it is appropriate to continue treatment with the Aknemycin preparations Aknemycin Ointment or Aknemycin Emulsion, as these dry out the skin to a lesser extent. Aknemycin Solution can also be applied alternately with these preparations.
    In individual cases the above symptoms may also be signs of a hypersensitivity reaction to the active substance or any of the excipients (allergic contact eczema).
    After prolonged treatment the symptoms may become worse through the development of resistance and gram-negative folliculitis.

    Drug interactions

    Carbamazepine, cyclosporin, disopyramide, theophylline, bromocriptine, midazolam, triazolam. Coumarin anticoagulants, ergot alkaloids, digoxin. Alfentanil, lincomycin, clindamycin, terfenadine, astemizole, cisapride.

    Pregnancy and Lactation

    Pregnancy: Aknemycin can be used during pregnancy as the active substance erythromycin is not absorbed percutaneously to any significant extent and therefore no undesirable effects on the unborn child are to be expected.
    Lactation: Aknemycin can be used during the lactation period. In order to avoid the oral intake of erythromycin by the infant during the first few weeks of life, the child’s mouth should be prevented from coming into contact with the areas of the body that have been treated.


    No case of overdose has been reported.

    Almirall Hermal GmbH Germany
    Licence holder